INS and type 1 diabetes mellitus: Overall, further clinical trials with tolerizing DNA plasmids to proinsulin and other islet cell autoantigens remain a worthy pursuit to potentially treat, prevent, and perhaps even ‘cure’ or ‘prevent’ T1D [46].